Patent · US Active

Medical devices incorporating collagen inhibitors

US8668703B2 · kind B2 · utility

8Cited by
27References
33Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 30, 2007
Grant dateMar 11, 2014
Priority date
Expiry dateFeb 2, 2029

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY10S606/907
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided herein are implantable or insertable biomedical devices comprising a substrate and a collagen inhibitor on or in said substrate, and methods of treatment using the same. In some embodiments, the device is a urethral, ureteral, or nephroureteral catheter or stent. In some embodiments, the device is an absorbable esophageal or tracheal stent. Wound closure devices are also provided herein, including a substrate and a collagen inhibitor on or in the substrate. Also provided are surgical packings, including a substrate and a collagen inhibitor on or in the substrate. A barrier material for preventing adhesions in a subject is further provided, including a preformed or in situ formable barrier substrate and a collagen inhibitor on or in the substrate. Kits comprising the coated substrates are also provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.